@FierceBiotech: $MRK and $NVO join an open-source R&D club with $AMGN, $SNY and Ono. Report | Follow @FierceBiotech
@JohnCFierce: Game-changer: A new plan takes shape to spur the U.K.'s biotech cluster. More | Follow @JohnCFierce
@DamianFierce: Schleifer on PCSK9 launches: Initial splash w/ severe patients and "early adopters" followed by a 2nd boom when outcomes data come out $REGN. | Follow @DamianFierce
> Shares of Amicus Therapeutics surged this morning after the biotech released some preclinical results on its therapy for Pompe disease. Release
> Isis ($ISIS) earned a $5 million milestone from Biogen Idec ($BIIB) in exchange for progress on an unidentified neurological disorder. Release
Medical Device News
@FierceMedDev: Biosensors Japan's PhIII trial of drug eluting has enrolled patients. More | Follow @FierceMedDev
@VarunSaxena2: Check out these next-gen devices in the incubator pipeline: (Lots of pictures of new devices.) Report | Follow @VarunSaxena2
@EmilyWFierce: Pioneer in BRCA1 research once received a cease-and-desist letter from $MYGN's legal department. NYT story | Follow @EmilyWFierce
> Ahead of BD deal close, CareFusion partners to sell ventilators, sleep apnea device. Story
> Days after permanent injunction, Maquet is whacked with another FDA recall. Article
Pharma News
@FiercePharma: ICYMI yesterday: Serum Institute and Cipla in early merger talks. Story from FierceVaccines | Follow @FiercePharma
@CarlyHFierce: ICYMI yesterday: Daiichi's new clot-fighter Savaysa can't make up for $2.6B Benicar patent loss: analysts. Article | Follow @CarlyHFierce
> FDA puts off Mylan's Nexium generic, giving Teva's version free rein. More
> Showdown time for Amgen, Sandoz, with Neupogen biosim hearing set March 2. Article
Pharma Manufacturing News
> Cambrex ponies up $50M for another expansion of its Iowa API plant. News
> New Jersey company invests $1M in plant, now offers contract manufacturing. Article
> FDA letter takes issue with Micro Labs' data practices. Report
> China FDA orders respiratory API recalled after 'fur' like impurities found. Story
> Cipla to build a manufacturing plant in Morocco with local partners. Article
Biotech Research News
> UC Davis team finds a prime drug candidate for neuropathic pain. More
> Neuroscience project tries to put the immune system to work against Alzheimer's. Report
> Psychedelic drug shows promise as a new treatment for allergic asthma. Article
> Peptide could play a role in preventing binge eating, obesity. Item
> Antibody developed by NTU-led team in Singapore tracks flu recovery. Story